Reshma Rangwala

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

Affiliation history

Recorded current and former roles; source labels appear when available.

Recorded roles and earnings-call appearances connecting this person to public companies.

KPTI

Current role

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year	Company	Role	Salary	Bonus	Stock awards	Option awards	Incentive	Other	Total
2025	Karyopharm Therapeutics Inc. (KPTI)	Chief Medical Officer and Head of Research	$567,736	$1,051,096	$79,492	$120,766	$178,837	$18,207	$2,016,134
2024	Karyopharm Therapeutics Inc. (KPTI)	Chief Medical Officer and Head of Research	$567,736	—	$315,794	—	$222,907	$18,007	$1,124,444
2023	Karyopharm Therapeutics Inc. (KPTI)	Chief Medical Officer and Head of Research	$545,900	—	$450,465	—	$210,717	$20,707	$1,227,789

No earnings-call appearances or filed executive changes recorded yet.